Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
14.52
-1.10 (-7.04%)
Apr 29, 2026, 11:14 AM EDT - Market open
Corvus Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 4.58 | 8.74 | 12.62 | 13.16 | 63.46 | Upgrade
|
| Short-Term Investments | 52.17 | 43.22 | 14.53 | 29.14 | 5.99 | Upgrade
|
| Cash & Short-Term Investments | 56.75 | 51.96 | 27.15 | 42.3 | 69.45 | Upgrade
|
| Cash Growth | 9.21% | 91.40% | -35.82% | -39.09% | 56.92% | Upgrade
|
| Accounts Receivable | 0.04 | 0.08 | 0.03 | 0.59 | 0.51 | Upgrade
|
| Other Receivables | 0.34 | 0.14 | 0.04 | 0.05 | 0.03 | Upgrade
|
| Receivables | 0.37 | 0.22 | 0.06 | 0.63 | 0.54 | Upgrade
|
| Prepaid Expenses | 0.17 | 0.47 | 0.38 | 0.43 | 0.45 | Upgrade
|
| Other Current Assets | 0.92 | 1.76 | 0.37 | 0.29 | 0.87 | Upgrade
|
| Total Current Assets | 58.21 | 54.41 | 27.96 | 43.66 | 71.31 | Upgrade
|
| Property, Plant & Equipment | 1.06 | 1.33 | 1.39 | 2.57 | 3.64 | Upgrade
|
| Long-Term Investments | 10.99 | 12.54 | 16.12 | 21.88 | 34.27 | Upgrade
|
| Other Long-Term Assets | 0.86 | 0.63 | 0.09 | 0.13 | 0.24 | Upgrade
|
| Total Assets | 71.12 | 68.91 | 45.55 | 68.24 | 109.46 | Upgrade
|
| Accounts Payable | 2.49 | 2.58 | 1.53 | 1.98 | 1.57 | Upgrade
|
| Accrued Expenses | 6.25 | 3.44 | 3.73 | 7.39 | 6.96 | Upgrade
|
| Current Portion of Leases | 0.4 | 0.19 | 1.37 | 1.23 | 1.05 | Upgrade
|
| Other Current Liabilities | 0.24 | 29.2 | 0.25 | 0.16 | 0.12 | Upgrade
|
| Total Current Liabilities | 9.38 | 35.4 | 6.87 | 10.75 | 9.69 | Upgrade
|
| Long-Term Leases | 0.53 | 0.94 | - | 1.37 | 2.6 | Upgrade
|
| Total Liabilities | 9.91 | 36.34 | 6.87 | 12.13 | 12.29 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 474.39 | 430.86 | 374.36 | 364.36 | 361.67 | Upgrade
|
| Retained Earnings | -412.29 | -397.01 | -334.72 | -307.69 | -266.38 | Upgrade
|
| Comprehensive Income & Other | -0.9 | -1.29 | -0.97 | -0.56 | 1.87 | Upgrade
|
| Total Common Equity | 61.21 | 32.57 | 38.68 | 56.12 | 97.16 | Upgrade
|
| Shareholders' Equity | 61.21 | 32.57 | 38.68 | 56.12 | 97.16 | Upgrade
|
| Total Liabilities & Equity | 71.12 | 68.91 | 45.55 | 68.24 | 109.46 | Upgrade
|
| Total Debt | 0.94 | 1.12 | 1.37 | 2.6 | 3.65 | Upgrade
|
| Net Cash (Debt) | 55.81 | 50.84 | 25.78 | 39.7 | 65.8 | Upgrade
|
| Net Cash Growth | 9.78% | 97.25% | -35.08% | -39.67% | 56.87% | Upgrade
|
| Net Cash Per Share | 0.70 | 0.83 | 0.54 | 0.85 | 1.57 | Upgrade
|
| Filing Date Shares Outstanding | 83.99 | 68.14 | 49.04 | 46.57 | 46.55 | Upgrade
|
| Total Common Shares Outstanding | 74.7 | 67.9 | 49.04 | 46.55 | 46.55 | Upgrade
|
| Working Capital | 48.83 | 19.01 | 21.09 | 32.91 | 61.62 | Upgrade
|
| Book Value Per Share | 0.82 | 0.48 | 0.79 | 1.21 | 2.09 | Upgrade
|
| Tangible Book Value | 61.21 | 32.57 | 38.68 | 56.12 | 97.16 | Upgrade
|
| Tangible Book Value Per Share | 0.82 | 0.48 | 0.79 | 1.21 | 2.09 | Upgrade
|
| Machinery | 2.84 | 2.69 | 2.85 | 2.82 | 2.62 | Upgrade
|
| Leasehold Improvements | 0.03 | 2.08 | 2.08 | 2.08 | 2.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.